http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005281823-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6a3325a1d33b54446ae53cd0289ac188
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ff0b9fffafdda728332de88b21270f36
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-567
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-3955
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6869
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-244
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-24
filingDate 2005-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94f508cbfa00fd9f791426abf8cc8728
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77f625d14ad4721b4ee9125b249a80b7
publicationDate 2005-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2005281823-A1
titleOfInvention Antibodies against human IL-12
abstract The present invention relates to novel p75 heterodimer specific anti-human IL-12 antibodies that are characterized by a higher potency and greater efficacy in neutralizing human IL-12 bioactivity than known heterodimer specific IL-12 monoclonal antibodies. The heterodimer specific antibodies recognize one or more epitopes of the human IL-12 p75 heterodimer, but do not bind to the p40 subunit alone. The heterodimer specific IL-12 antibodies neutralize rhesus monkey IL-12 bioactivity with a potency similar to their potency for neutralizing human IL-12 bioactivity making them useful IL-12 antagonists for in vivo studies in the rhesus monkey.
priorityDate 1998-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5853697-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6225117-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5569454-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4569794-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5650492-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5648072-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7026456-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5853721-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5457038-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5780597-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6255117-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5648467-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4473555-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5530101-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5811523-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID99282
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226429141
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135728745
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16122514
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406586
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128531660
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24749
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226423730
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID379
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID85880
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395153
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21226089
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20057191
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406585
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409524
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226428214
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5904
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395895
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409525
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226428215
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23830
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395375
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66250
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399961
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402238
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405839
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394880
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405840
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2154
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394438
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226455395
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65403
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5363269
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5364430
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280965
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408028
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129322018
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1134
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5789
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57199466
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19649
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID352546
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396020
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21226069
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395152
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395500
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57134040
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57422521

Total number of triples: 86.